SMTL ID : 4hfr.2 (1 other biounit)

Human 11beta-Hydroxysteroid Dehydrogenase Type 1 in complex with an orally bioavailable acidic inhibitor AZD4017.

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.73 Å

Oligo State

homo-tetramer

Ligands

4 x NAP: NADP NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE(Non-covalent)

NAP.1: 30 residues within 4Å: Chain A: G.21, A.22, S.23, K.24, G.25, I.26, A.45, R.46, S.47, G.71, T.72, M.73, N.99, H.100, I.101, V.122, Y.127, V.148, S.149, S.150, Y.163, K.167, L.195, G.196, L.197, I.198, T.200, T.202, A.203 Ligands: 14M.2 19 PLIP interactions: 19 interactions with chain A Hydrophobic interactions: A:L.195 Hydrogen bonds: A:G.21, A:S.23, A:S.23, A:K.24, A:I.26, A:R.46, A:S.47, A:T.72, A:T.72, A:M.73, A:N.99, A:I.101, A:Y.127, A:K.167, A:I.198, A:I.198 Salt bridges: A:K.24, A:R.46 NAP.3: 31 residues within 4Å: Chain B: G.21, A.22, S.23, K.24, G.25, I.26, A.45, R.46, S.47, G.71, T.72, M.73, N.99, H.100, I.101, T.102, V.122, Y.127, V.148, S.149, S.150, Y.163, K.167, L.195, G.196, L.197, I.198, T.200, T.202, A.203 Ligands: 14M.4 23 PLIP interactions: 23 interactions with chain B Hydrophobic interactions: B:L.195, B:I.198 Hydrogen bonds: B:S.23, B:S.23, B:K.24, B:K.24, B:I.26, B:R.46, B:S.47, B:T.72, B:T.72, B:M.73, B:N.99, B:N.99, B:I.101, B:Y.127, B:K.167, B:I.198, B:I.198, B:T.200, B:T.202 Salt bridges: B:K.24, B:R.46 NAP.5: 30 residues within 4Å: Chain C: G.21, A.22, S.23, K.24, G.25, I.26, A.45, R.46, S.47, G.71, T.72, M.73, N.99, H.100, I.101, V.122, Y.127, V.148, S.149, S.150, Y.163, K.167, L.195, G.196, L.197, I.198, T.200, T.202, A.203 Ligands: 14M.6 20 PLIP interactions: 20 interactions with chain C Hydrophobic interactions: C:L.195 Hydrogen bonds: C:G.21, C:S.23, C:S.23, C:K.24, C:I.26, C:R.46, C:S.47, C:T.72, C:M.73, C:N.99, C:I.101, C:Y.163, C:K.167, C:I.198, C:I.198, C:T.200, C:T.202 Salt bridges: C:K.24, C:R.46 NAP.7: 31 residues within 4Å: Chain D: G.21, A.22, S.23, K.24, G.25, I.26, A.45, R.46, S.47, G.71, T.72, M.73, N.99, H.100, I.101, T.102, V.122, Y.127, V.148, S.149, S.150, Y.163, K.167, L.195, G.196, L.197, I.198, T.200, T.202, A.203 Ligands: 14M.8 20 PLIP interactions: 20 interactions with chain D Hydrophobic interactions: D:L.195, D:I.198 Hydrogen bonds: D:S.23, D:S.23, D:K.24, D:K.24, D:I.26, D:R.46, D:S.47, D:T.72, D:M.73, D:N.99, D:N.99, D:I.101, D:Y.163, D:K.167, D:I.198, D:I.198 Salt bridges: D:K.24, D:R.46

4 x 14M: {(3S)-1-[5-(cyclohexylcarbamoyl)-6-(propylsulfanyl)pyridin-2-yl]piperidin-3-yl}acetic acid(Non-covalent)

14M.2: 16 residues within 4Å: Chain A: I.101, T.104, L.106, S.150, L.151, Y.157, P.158, V.160, Y.163, G.196, L.197, M.213, D.239, T.244 Chain B: Y.260 Ligands: NAP.1 8 PLIP interactions: 6 interactions with chain A, 2 interactions with chain B Hydrophobic interactions: A:I.101, A:L.106, A:L.197, B:Y.260, B:Y.260 Hydrogen bonds: A:S.150, A:Y.163, A:L.197 14M.4: 14 residues within 4Å: Chain A: Y.260 Chain B: T.104, L.106, S.150, L.151, Y.157, P.158, V.160, Y.163, G.196, L.197, D.239, T.244 Ligands: NAP.3 8 PLIP interactions: 6 interactions with chain B, 2 interactions with chain A Hydrophobic interactions: B:L.106, B:Y.157, A:Y.260, A:Y.260 Hydrogen bonds: B:S.150, B:Y.163, B:L.197, B:T.244 14M.6: 16 residues within 4Å: Chain C: I.101, T.104, L.106, S.150, L.151, Y.157, P.158, V.160, Y.163, G.196, L.197, M.213, D.239, T.244 Chain D: Y.260 Ligands: NAP.5 7 PLIP interactions: 5 interactions with chain C, 2 interactions with chain D Hydrophobic interactions: C:I.101, C:L.106, C:L.197, D:Y.260, D:Y.260 Hydrogen bonds: C:S.150, C:L.197 14M.8: 14 residues within 4Å: Chain C: Y.260 Chain D: T.104, L.106, S.150, L.151, Y.157, P.158, V.160, Y.163, G.196, L.197, D.239, T.244 Ligands: NAP.7 8 PLIP interactions: 6 interactions with chain D, 2 interactions with chain C Hydrophobic interactions: D:L.106, D:Y.157, C:Y.260, C:Y.260 Hydrogen bonds: D:S.150, D:L.197, D:T.244, D:T.244

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Scott, J.S. et al., Discovery of a Potent, Selective, and Orally Bioavailable Acidic 11 -Hydroxysteroid Dehydrogenase Type 1 (11 -HSD1) Inhibitor: Discovery of 2-[(3S)-1-[5-(Cyclohexylcarbamoyl)-6-propylsulfanylpyridin-2-yl]-3-piperidyl]acetic Acid (AZD4017). J.Med.Chem. (2012)

Release Date

2012-10-17

Peptides

Corticosteroid 11-beta-dehydrogenase isozyme 1: ABCD

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

C
A

D
B

Corticosteroid 11-beta-dehydrogenase isozyme 1

Related Entries With Identical Sequence